back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-05-14 11:30 Tx date 2019-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-189.10
-155 vol $1.22 each |
1,162 | |
| Filed 2019-05-14 11:30 Tx date 2019-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$666.12
+546 vol $1.22 each |
1,317 | |
| Filed 2019-05-14 11:28 Tx date 2019-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
$-666.12
-546 vol $1.22 each |
20,560 | |
| Filed 2018-05-11 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
-547 vol |
21,106 | |
| Filed 2018-05-11 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+547 vol |
932 | |
| Filed 2018-05-11 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-685.86
-161 vol $4.26 each |
771 | |
| Filed 2018-02-14 Tx date 2018-02-12 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
66,740 | |
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-1,526.04
-162 vol $9.42 each |
385 | |
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
36 - Conversion or exchange
|
-547 vol |
21,653 | |
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+547 vol |
547 | |
| Filed 2017-05-11 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-27 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
37 - Stock split or consolidation
|
-6,564 vol |
1,640 | |
| Filed 2016-12-27 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
56 - Grant of rights
|
+20,560 vol |
22,200 | |
| Filed 2016-12-27 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+41,740 vol |
41,740 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+8,204 vol |
8,204 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Louis, Roger
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|